tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (TSE:APLI)
TSX:APLI
Canadian Market

Appili Therapeutics Inc Class A (APLI) Income Statement

Compare
26 Followers

Appili Therapeutics Inc Class A Income Statement

Last quarter (Q2 2026), Appili Therapeutics Inc Class A's total revenue was C$103.94K, an increase of 2116.10% from the same quarter last year. In Q2, Appili Therapeutics Inc Class A's net income was C$-989.07K. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 24Dec 23Dec 22Dec 20
Total Revenue
C$ 827.41KC$ 100.44KC$ 334.18KC$ 1.39MC$ 0.00
Gross Profit
C$ 827.41KC$ 100.44KC$ 327.91KC$ 1.39MC$ -14.84K
Operating Expenses
C$ 2.92MC$ 291.28KC$ 8.11MC$ 24.95MC$ 16.28M
Depreciation and Amortization
C$ 13.66KC$ 13.46KC$ 6.27KC$ 12.64KC$ 14.84K
EBITDA
C$ -2.07MC$ 360.57KC$ -8.10MC$ -23.51MC$ -14.87M
Operating Income
C$ -2.16MC$ -190.84KC$ -7.91MC$ -24.68MC$ -16.30M
Other Income/Expenses
C$ -1.55MC$ -2.42MC$ -1.29MC$ -401.36KC$ 1.34M
Pretax Income
C$ -3.71MC$ -2.61MC$ -9.21MC$ -25.08MC$ -14.95M
Net Income
C$ -3.78MC$ -2.62MC$ -9.24MC$ -25.12MC$ -14.33M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.02C$ -0.08C$ -0.38C$ -0.24
Diluted EPS
C$ -0.03C$ -0.02C$ -0.08C$ -0.38C$ -0.24
Weighted Average Shares Outstanding
121.27M 121.27M 113.73M 66.73M 59.18M
Weighted Average Shares Outstanding (Diluted)
121.27M 121.27M 113.73M 66.73M 59.18M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History